|
PML
MCID: PRG009
|
Progressive Multifocal Leukoencephalopathy malady |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 31NINDS, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Progressive multifocal leukoencephalopathy (PML) is a neurological disorder that damages the myelin that covers and protects nerves in the white matter of the brain. It is caused by the JC virus (JCV). By age 10, most people have been infected with this virus, but it rarely causes symptoms unless the immune system becomes severely weakened. The disease occurs, rarely, in organ transplant patients; people undergoing chronic corticosteroid or immunosuppressive therapy; and individuals with cancer, such as Hodgkin’s disease, lymphoma, and sarcoidosis. PML is most common among individuals with acquired immune deficiency syndrome (AIDS).30
MalaCards: Progressive Multifocal Leukoencephalopathy, also known as leukoencephalopathy, progressive multifocal, is related to leukemia and cerebritis. An important gene associated with Progressive Multifocal Leukoencephalopathy is CTXN2 (cortexin 2), and among its related pathways are Primary immunodeficiency and Intestinal immune network for IgA production. The compounds acyclovir and tuberculin have been mentioned in the context of this disorder. Affiliated tissues include brain, kidney and t cells, and related mouse phenotypes are hematopoietic system and skeleton. Disease Ontology: A viral infectious disease that involves reactivation of jc polyomavirus in immune-compromised individuals which causes the loss of white matter (which is made up of myelin, a substance the surrounds and protects nerve fibers) in multiple areas of the brain. the symptoms include hemiparesis, aphasia, dysarthria, hemianopia, cognitive impairment and coma.6 NINDS: Progressive multifocal leukoencephalopathy (PML) is a disease of the white matter of the brain, caused by a virus infection that targets cells that make myelin--the material that insulates nerve cells (neurons). 31 Wikipedia: Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal...44 more... |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 31NINDS, 8DISEASES, 43UMLS, 32Novoseek , 24MeSH, 27NCIt, 40SNOMED-CT, 19ICD9CM See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for progressive multifocal leukoencephalopathy Drug clinical trials:Search ClinicalTrials for progressive multifocal leukoencephalopathy Search NIH Clinical Center for progressive multifocal leukoencephalopathy Search CenterWatch for progressive multifocal leukoencephalopathy |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to progressive multifocal leukoencephalopathy:22Brain, Kidney, T cells
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to progressive multifocal leukoencephalopathy:25 (show all 12)
|
Publications for genes affiliated with Progressive Multifocal Leukoencephalopathy
|
Sources: 35PubMed See all sources |
Articles related to progressive multifocal leukoencephalopathy:(show all 18)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 20KEGG, 36QIAGEN, 37R&D Systems See all sources |
Pathways related to progressive multifocal leukoencephalopathy according to GeneDecks:
|
|
Sources: 32Novoseek , 42Tocris Bioscience, 9DrugBank, 18HMDB, 34PharmGKB See all sources |
Compounds related to progressive multifocal leukoencephalopathy according to GeneDecks:(show top 50) (show all 70)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to progressive multifocal leukoencephalopathy according to GeneDecks:
Biological processes related to progressive multifocal leukoencephalopathy according to GeneDecks:(show all 7)
|
